Listed by the USPTO as AULAKH, CHARANJIT
Tech Center 1600 • Art Units: 1621 1625 1629 1652
This examiner grants 81% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18279903 | PROCESS FOR PREPARING A MELAMINE CONDENSATION PRODUCT | Final Rejection | BASF SE |
| 17919650 | TARGETING THE PALMOTYLATION/DEPALMOTYLATION CYCLE TO TREAT INFLAMMATORY DISEASES | Final Rejection | CORNELL UNIVERSITY |
| 18293923 | INTEGRATED PROCESS FOR 5-(METHOXYCARBONYL)FURAN-2-CARBOXYLIC ACID (MCFC) | Final Rejection | Eastman Chemical Company |
| 18265337 | Compound And Organic Light Emitting Device Comprising The Same | Non-Final OA | LG Chem, Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy80.7% of resolved applications examined by Charanjit Aulakh were allowed (1,790 resolved cases), compared with 46.0% across Art Unit 1621 over the last five years.
This examiner's interview lift is -14.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Charanjit Aulakh took 754 days on average from filing to allowance.
Charanjit Aulakh examines applications in Art Unit 1621 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
